These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12869768)

  • 1. Funding fertility: issues in the allocation and distribution of resources to assisted reproduction technologies.
    Devlin N; Parkin D
    Hum Fertil (Camb); 2003 May; 6 Suppl 1():S2-6. PubMed ID: 12869768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should uterus transplants be publicly funded?
    Wilkinson S; Williams NJ
    J Med Ethics; 2016 Sep; 42(9):559-65. PubMed ID: 26670671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models for future delivery of care in infertility: the role of the private sector.
    Brinsden PR
    Hum Fertil (Camb); 2003 May; 6 Suppl 1():S25-7. PubMed ID: 12869774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First line fertility treatment strategies regarding IUI and IVF require clinical evidence.
    Bahadur G; Homburg R; Muneer A; Racich P; Alangaden T; Al-Habib A; Okolo S
    Hum Reprod; 2016 Jun; 31(6):1141-6. PubMed ID: 27076499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infertility in resource-constrained settings: moving towards amelioration.
    Hammarberg K; Kirkman M
    Reprod Biomed Online; 2013 Feb; 26(2):189-95. PubMed ID: 23260034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptable cost for the patient and society.
    Chambers GM; Adamson GD; Eijkemans MJ
    Fertil Steril; 2013 Aug; 100(2):319-27. PubMed ID: 23905708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models for future delivery of care in infertility-- hospital-based services.
    Ledger WL
    Hum Fertil (Camb); 2003 May; 6 Suppl 1():S22-4. PubMed ID: 12869773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.
    Hoomans T; Fenwick EA; Palmer S; Claxton K
    Value Health; 2009; 12(2):315-24. PubMed ID: 18657098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century.
    Inhorn MC; Patrizio P
    Hum Reprod Update; 2015; 21(4):411-26. PubMed ID: 25801630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the societal and individual preferences for fertility treatment in Australia: study protocol for stated preference discrete choice experiments.
    Botha W; Donnolley N; Shanahan M; Chambers GM
    BMJ Open; 2018 Feb; 8(2):e020509. PubMed ID: 29444788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to assisted reproductive technologies in sub-Saharan Africa: fertility professionals' views.
    Whittaker A; Gerrits T; Hammarberg K; Manderson L
    Sex Reprod Health Matters; 2024 Dec; 32(1):2355790. PubMed ID: 38864373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: models for future delivery of care in infertility.
    Denton J
    Hum Fertil (Camb); 2003 May; 6 Suppl 1():S7-8. PubMed ID: 12869769
    [No Abstract]   [Full Text] [Related]  

  • 13. Indonesian infertility patients' health seeking behaviour and patterns of access to biomedical infertility care: an interviewer administered survey conducted in three clinics.
    Bennett LR; Wiweko B; Hinting A; Adnyana IB; Pangestu M
    Reprod Health; 2012 Sep; 9():24. PubMed ID: 23020912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who should pay for assisted reproductive techniques? Answers from patients, professionals and the general public in Germany.
    Rauprich O; Berns E; Vollmann J
    Hum Reprod; 2010 May; 25(5):1225-33. PubMed ID: 20228390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms.
    Connolly MP; Ledger W; Postma MJ
    Hum Fertil (Camb); 2010 Mar; 13(1):13-8. PubMed ID: 19903117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assisted Reproductive Technologies in Alberta: An Economic Analysis to Inform Policy Decision-Making.
    Vaidya A; Stafinski T; Nardelli A; Motan T; Menon D
    J Obstet Gynaecol Can; 2015 Dec; 37(12):1122-30. PubMed ID: 26637087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic aspects of infertility care: a challenge for researchers and clinicians.
    ESHRE Capri Workshop Group
    Hum Reprod; 2015 Oct; 30(10):2243-8. PubMed ID: 26141712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term fiscal impact of funding cuts to Danish public fertility clinics.
    Connolly MP; Postma MJ; Crespi S; Andersen AN; Ziebe S
    Reprod Biomed Online; 2011 Dec; 23(7):830-7. PubMed ID: 22033399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resources for infertility treatment.
    Winston RM
    Baillieres Clin Obstet Gynaecol; 1991 Sep; 5(3):551-73. PubMed ID: 1954728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New reproductive technologies: Equity and access to reproductive health care.
    Henifin MS
    J Soc Issues; 1993; 49(2):61-74. PubMed ID: 17165238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.